Blood test could reveal hidden cancer spread in colorectal patients
NCT ID NCT07224724
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
The EXELION study is testing a new blood test that looks for tiny particles called exosomal microRNAs to find out if colorectal cancer has spread beyond the liver. Current scans often miss small or hidden metastases, which can affect treatment options. The study will enroll 500 adults with metastatic colorectal cancer to see how accurate this liquid biopsy is compared to standard imaging.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
exosomal microRNA panel measured in blood
What this could lead to
If successful, this blood test could help doctors find small cancer spread that scans miss, leading to better treatment choices and possibly more patients eligible for surgery.
What could go wrong
This is an early-stage study focused on developing and testing the test's accuracy. It may not prove better than current imaging, and the test is not yet available for routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CARCINOMA (MCRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••